178 related articles for article (PubMed ID: 19383289)
1. Characterization of breast precancerous lesions and myoepithelial hyperplasia in sclerosing adenosis with apocrine metaplasia.
Celis JE; Moreira JM; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans V; Rank F
Mol Oncol; 2007 Jun; 1(1):97-119. PubMed ID: 19383289
[TBL] [Abstract][Full Text] [Related]
2. Loss of heterozygosity in fibrocystic change of the breast: genetic relationship between benign proliferative lesions and associated carcinomas.
Washington C; Dalbègue F; Abreo F; Taubenberger JK; Lichy JH
Am J Pathol; 2000 Jul; 157(1):323-9. PubMed ID: 10880402
[TBL] [Abstract][Full Text] [Related]
3. Identification of a subset of breast carcinomas characterized by expression of cytokeratin 15: relationship between CK15+ progenitor/amplified cells and pre-malignant lesions and invasive disease.
Celis JE; Gromova I; Cabezón T; Gromov P; Shen T; Timmermans-Wielenga V; Rank F; Moreira JM
Mol Oncol; 2007 Dec; 1(3):321-49. PubMed ID: 19383306
[TBL] [Abstract][Full Text] [Related]
4. Blunt duct adenosis: a separate entity from columnar cell lesions?
de Boer M; van Diest PJ
J Clin Pathol; 2022 Jan; 75(1):5-9. PubMed ID: 33858936
[TBL] [Abstract][Full Text] [Related]
5. All Benign and Malignant Apocrine Breast Lesions Over-Express Claudin 1 and 3 and Are Negative for Claudin 4.
Shousha S; Anscombe O; McFarlane T
Pathol Oncol Res; 2020 Apr; 26(2):1073-1078. PubMed ID: 31044387
[TBL] [Abstract][Full Text] [Related]
6. Multiplicity of benign breast disease lesions and breast cancer risk in African American women.
Patil V; Ruterbusch JJ; Chen W; Boerner JL; Abdulfatah E; Alosh B; Pardeshi V; Shaik AN; Bandyopadhyay S; Ali-Fehmi R; Cote ML
Front Oncol; 2024; 14():1410819. PubMed ID: 38817898
[TBL] [Abstract][Full Text] [Related]
7. Microenvironmental influences that drive progression from benign breast disease to invasive breast cancer.
Cichon MA; Degnim AC; Visscher DW; Radisky DC
J Mammary Gland Biol Neoplasia; 2010 Dec; 15(4):389-97. PubMed ID: 21161341
[TBL] [Abstract][Full Text] [Related]
8. Apocrine and clear cell metaplasia in the gallbladder: the first finding in the medical literature.
Al-Janabi MH
Oxf Med Case Reports; 2024 May; 2024(5):omae052. PubMed ID: 38784780
[TBL] [Abstract][Full Text] [Related]
9. Apocrine lesions of the breast.
Quinn CM; D'Arcy C; Wells C
Virchows Arch; 2022 Jan; 480(1):177-189. PubMed ID: 34537861
[TBL] [Abstract][Full Text] [Related]
10. Immunoexpression of the GCDFP-15 Marker in Different Grades of Breast Carcinoma.
Shirian F; Kheradmand P; Ranjbari N; Shahbazian H; Latifi SM
Iran J Pathol; 2023; 18(1):75-81. PubMed ID: 37383152
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of Estrogen Receptor α in Mammary Glands of Aging Mice Is Associated with a Proliferative Risk Signature and Generation of Estrogen Receptor α-Positive Mammary Adenocarcinomas.
Furth PA; Wang W; Kang K; Rooney BL; Keegan G; Muralidaran V; Wong J; Shearer C; Zou X; Flaws JA
Am J Pathol; 2023 Jan; 193(1):103-120. PubMed ID: 36464513
[TBL] [Abstract][Full Text] [Related]
12. Breast Atypical Apocrine Adenosis: A Case Report and Literature Review.
Khan KA; Alkistawi F; Idaewor P; Barron M; Saad Abdalla Al-Zawi A
Cureus; 2020 Jun; 12(6):e8624. PubMed ID: 32685294
[TBL] [Abstract][Full Text] [Related]
13. S100A7 promotes the migration, invasion and metastasis of human cervical cancer cells through epithelial-mesenchymal transition.
Tian T; Li X; Hua Z; Ma J; Wu X; Liu Z; Chen H; Cui Z
Oncotarget; 2017 Apr; 8(15):24964-24977. PubMed ID: 28212564
[TBL] [Abstract][Full Text] [Related]
14. Sclerosing adenosis as a predictor of breast cancer bilaterality and multicentricity.
Oiwa M; Endo T; Ichihara S; Moritani S; Hasegawa M; Iwakoshi A; Sato Y; Morita T; Hayashi T; Kato A
Virchows Arch; 2015 Jul; 467(1):71-8. PubMed ID: 25838080
[TBL] [Abstract][Full Text] [Related]
15. FABP7 and HMGCS2 are novel protein markers for apocrine differentiation categorizing apocrine carcinoma of the breast.
Gromov P; Espinoza JA; Talman ML; Honma N; Kroman N; Timmermans Wielenga V; Moreira JM; Gromova I
PLoS One; 2014; 9(11):e112024. PubMed ID: 25389781
[TBL] [Abstract][Full Text] [Related]
16. Septic disruption of lactiferous ducts with heterogeneous carcinoma of the breast in a lactating woman.
Naim M; John VT; Gaur K; Anees A
BMJ Case Rep; 2010 Aug; 2010():. PubMed ID: 22767674
[TBL] [Abstract][Full Text] [Related]
17. Tissue proteomics of the human mammary gland: towards an abridged definition of the molecular phenotypes underlying epithelial normalcy.
Moreira JM; Cabezón T; Gromova I; Gromov P; Timmermans-Wielenga V; Machado I; Llombart-Bosch A; Kroman N; Rank F; Celis JE
Mol Oncol; 2010 Dec; 4(6):539-61. PubMed ID: 21036680
[TBL] [Abstract][Full Text] [Related]
18. Nuclear S100A7 is associated with poor prognosis in head and neck cancer.
Tripathi SC; Matta A; Kaur J; Grigull J; Chauhan SS; Thakar A; Shukla NK; Duggal R; DattaGupta S; Ralhan R; Siu KW
PLoS One; 2010 Aug; 5(8):e11939. PubMed ID: 20689826
[TBL] [Abstract][Full Text] [Related]
19. Up-regulated proteins in the fluid bathing the tumour cell microenvironment as potential serological markers for early detection of cancer of the breast.
Gromov P; Gromova I; Bunkenborg J; Cabezon T; Moreira JM; Timmermans-Wielenga V; Roepstorff P; Rank F; Celis JE
Mol Oncol; 2010 Feb; 4(1):65-89. PubMed ID: 20005186
[TBL] [Abstract][Full Text] [Related]
20. Targeting migration inducting gene-7 inhibits carcinoma cell invasion, early primary tumor growth, and stimulates monocyte oncolytic activity.
Petty AP; Wright SE; Rewers-Felkins KA; Yenderrozos MA; Vorderstrasse BA; Lindsey JS
Mol Cancer Ther; 2009 Aug; 8(8):2412-23. PubMed ID: 19671748
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
